Curtis Lockshin - 11 Dec 2023 Form 4 Insider Report for Xenetic Biosciences, Inc. (XBIO)

Role
Chief Sciencific Officer
Signature
/s/ Curtis A. Lockshin
Issuer symbol
XBIO
Transactions as of
11 Dec 2023
Net transactions value
$0
Form type
4
Filing time
13 Dec 2023, 17:30:10 UTC
Previous filing
22 Feb 2023
Next filing
12 Sep 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction XBIO Stock Options Award $0 +10,000 $0.000000 10,000 11 Dec 2023 Common Stock 10,000 $3.88 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying the options will vest and become exercisable as follows: one-third of the shares shall vest on the first anniversary of December 11, 2023; the remaining two-thirds of the shares shall vest in eight equal quarterly installments commencing on March 11, 2025 and ending on December 11, 2026.